По вашему запросу найдено документов: 544

Страница 34 из 55

IREB2, CHRNA5, CHRNA3, FAM13A & HEDGEHOG INTERACTING PROTEIN GENES POLYMORPHISMS & RISK OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN TATAR POPULATION FROM RUSSIA
Korytina, G.F., Akhmadishina, L.Z., Viktorova, E.V., Kochetova, O.V., Viktorova, T.V. (2016)
Background objectives: Chronic obstructive pulmonary disease (COPD) is a complex chronic
Synthesis and biological activity of 2-[6-methyl-4-(thietan-3-yloxy)pyrimidin-2-ylthio]acetohydrazide derivatives
Meshcheryakova, S, Shumadalova, A, Beylerli, O, Gareev, I (2021)
]acetohydrazide derivatives was investigated. According to the literature, there are a lot of antimicrobial agents among
NEUROPHARMACOLOGICAL ANALYSIS OF THE ANTIDEPRESSANT ACTION OF 2-[3-METHYL-7-(THIETAN-3-YL)-1-ETHYLXANTH-8-YLTHIO] ACETIC ACID HYDRAZIDE
VALEEVA, L.A., DAVLYATOVA, G.G ., SHIMANOVSKII, N.L. (2020)
A compound with low toxicity and pronounced antidepressant activity upon single and long
СЛУЧАЙ ЯТРОГЕННОГО БОТУЛИЗМА ПРИ БОТУЛИНОТЕРАПИИ В КЛИНИЧЕСКОЙ ПРАКТИКЕ
Case of iatrogenic botulism after botulinotherapy in clinical practice
ИБАТУЛЛИН, РОБЕРТ АЛЬБЕРОВИЧ, МАГЖАНОВ, РИМ ВАЛЕЕВИЧ, Ibatullin, R.A., Magjanov, R.V. (2018)
, urology, stomatology, cosmetology, gastroenterology etc. Preparations of botulinum toxin type A (BTA
Influence of oral co-infection on the course of SARS-CoV-2
Nasibullina, A.Kh., Kabirova, M.F., Kabirov, I.R. (2021)
, with a confirmed diagnosis on admission International classification of diseases (ICD-X: J18
Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021
Bollyky, TJ, Hulland, EN, Barber, RM, Collins, JK, Kiernan, S, Moses, M, Pigott, DM, Reiner, RC, Sorensen, RJD, Abbafati, C, Adolph, C, Allorant, A, Amlag, JO, Aravkin, AY, Bang-Jensen, B, Carter, A, Castellano, R, Castro, E, Chakrabarti, S, Combs, E, Dai, XC, Dangel, WJ, Dapper, C, Deen, A, Duncan, BB, Earl, L, Erickson, M, Ewald, SB, Fedosseeva, T, Ferrari, AJ, Flaxman, AD, Fullman, N, Gakidou, E, Galal, B, Gallagher, J, Giles, JR, Guo, GR;, He, JW, Helak, M, Huntley, BM, Idrisov, B, Johanns, C, LeGrand, KE, Letourneau, ID, Lindstrom, A, Linebarger, E, Lotufo, PA, Lozano, R, Magistro, B, Malta, DC, Mansson, J, Herrera, AMM, Marinho, F, Mirkuzie, AH, Mokdad, AH, Monasta, L, Naik, P, Nomura, S, O'Halloran, JK, Odell, CM, Olana, LT, Ostroff, SM, Pasovic, M, Passos, VMD, Penberthy, L, Reinke, G, Santomauro, DF, Schmidt, MI, Sholokhov, A, Spurlock, E, Troeger, CE, Varavikova, E, Vo, AT, Vos, T, Walcott, R, Walker, A, Wigley, SD, Wiysonge, CS, Worku, NA, Wu, YF, Hanson, SW, Zheng, P, Hay, SI, Murray, CJL, Dieleman, JL (2022)
product (GDP) per capita, proportion of the population living below 100 m, and a proxy for previous
Innovative antimicrobial substances based on uracil S-derivatives
Meshcheryakova, S., Shumadalova, A., Beylerli, O., Gareev, I., Zhao, S., Wu, J. (2022)
that a development of new antibiotic compounds around known natural substances is a solution
Hybrid Approach of Fractional Generalized Pareto Motion and Cosine Similarity Hidden Markov Model for Solar Radiation Forecasting
Song, W., Deng, W., Chen, D., Jin, R., Kudreyko, A. (2023)
system’s reliability. Therefore, this study suggests a way to predict the intensity of solar irradiance
LONG-ACTING C-TERMINAL PEPTIDE-MODIFIED HGH (MOD-4023): RESULTS OF A SAFETY AND DOSE-FINDING STUDY IN GHD CHILDREN
Zelinska, N., Iotova, V., Skorodok, J., Malievsky, O., Peterkova, V., Samsonova, L., Rosenfeld, Ron G., Zadik, Zvi, Jaron-Mendelson, Michal, Koren, Ronit, Amitzi, Leanne, Raduk, Dmitri, Hershkovitz, Oren, Hart, Gili (2017)
low compliance as a result of inconvenience and distress in patients. Objective: C-terminal peptide
Safety, Efficacy and Long-Term Outcomes of Patients Treated with the Occlutech Paravalvular Leak Device for Significant Paravalvular Regurgitation
Onorato, EM, Alamanni, F, Muratori, M, Smolka, G, Wojakowski, W, Pysz, P, Zorinas, A, Zakarkaite, D, Eltchaninoff, H, Litzer, PY, Godart, F, Calvert, P, Christou, C, Mussayev, A, Missiroli, B, Buzaev, I, Curello, S, Tesorio, T, Bartorelli, AL (2022)
of the device with a proper closure of the PVL, defined as reduction in paravalvular regurgitation of >= one

Страница 34 из 55

Google Scholar
OpenDoar

Фасеты

Научный руководитель
Авторы
Ключевые слова
Год